Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Assets (2016 - 2025)

Biomerica's Assets history spans 15 years, with the latest figure at $6.0 million for Q4 2025.

  • For Q4 2025, Assets fell 17.05% year-over-year to $6.0 million; the TTM value through Nov 2025 reached $6.0 million, down 17.05%, while the annual FY2025 figure was $5.9 million, 35.76% down from the prior year.
  • Assets for Q4 2025 was $6.0 million at Biomerica, down from $6.9 million in the prior quarter.
  • Across five years, Assets topped out at $17.6 million in Q1 2022 and bottomed at $5.9 million in Q2 2025.
  • The 5-year median for Assets is $10.7 million (2022), against an average of $10.5 million.
  • The largest annual shift saw Assets surged 62.48% in 2021 before it tumbled 53.25% in 2023.
  • A 5-year view of Assets shows it stood at $14.8 million in 2021, then plummeted by 33.1% to $9.9 million in 2022, then increased by 19.41% to $11.8 million in 2023, then plummeted by 38.52% to $7.3 million in 2024, then decreased by 17.05% to $6.0 million in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Assets are $6.0 million (Q4 2025), $6.9 million (Q3 2025), and $5.9 million (Q2 2025).